National Health Investors, Inc. (NHI)
NYSE: NHI · Real-Time Price · USD
76.62
-0.53 (-0.69%)
At close: Apr 28, 2026, 4:00 PM EDT
76.61
-0.01 (-0.01%)
After-hours: Apr 28, 2026, 4:23 PM EDT
← View all transcripts

Earnings Call: Q3 2021

Nov 8, 2021

Operator

Greetings, and thank you for standing by. Welcome to the National Health Investors Q3 2021 conference call. During the presentation, all participants will be in a listen-only mode, and afterwards, we'll conduct a question-and-answer session. At that time, if you have a question, please press one followed by four on your telephone.

If at any time during the conference, you need to reach an operator, please press star 0. This conference is being recorded Monday, November 8th, 2021. Now I'd like to turn the conference over to Dana Hambly. Please go ahead.

Dana Hambly
VP of Finance & Investor Relations, National Health Investors

Thank you, and welcome to the National Health Investors conference call to review the company's results for the Q3 of 2021. On the call today are Eric Mendelsohn, President and CEO; Kevin Pascoe, Chief Investment Officer; John Spaid, Executive Vice President and Chief Financial Officer; and David Travis, Chief Accounting Officer. The results, as well as notice of the accessibility of this conference call on a listen-only basis, were released after the market closed today in a press release that's been covered by the financial media.

As a reminder, any statements in this conference call which are not historical facts are forward-looking statements. NHI cautions investors that any forward-looking statements may involve risks or uncertainties and are not guarantees of future performance. All forward-looking statements represent NHI's judgment as of the date of this conference call.

Investors are urged to carefully review various disclosures made by NHI and its periodic reports filed with the Securities and Exchange Commission, including the risk factors and other information disclosed in NHI's Form 10-Q for the quarter ended September 30th, 2021. Copies of these filings are available on the SEC's website at sec.gov or on NHI's website at nhireit.com.

In addition, certain terms used in this call are non-GAAP financial measures, reconciliations of which are provided in NHI's earnings release and related tables and schedules, which have been filed on Form 8-K with the SEC. Listeners are encouraged to review those reconciliations provided in the earnings release together with all other information provided in that release. I'll now turn the call over to our CEO, Eric Mendelsohn.

Eric Mendelsohn
President and CEO, National Health Investors

Hello, everyone. Thanks for joining us today. We've been working this year to transition NHI into a stronger company entering 2022, and we have accomplished a great deal. Our portfolio optimization efforts, including dispositions, tenant transitions, and rent restructuring, will have touched more than 120 of our senior housing properties or more than 50% of our entire portfolio. We expect these efforts to be largely concluded by the end of the Q1 of 2022.

While there are many I's to be dotted and T's to be crossed, we are pleased that we have established frameworks that fundamentally transform our partnerships with Bickford and our Legacy Holiday portfolio. The completed and pending dispositions greatly improve the health of the Bickford and Holiday portfolios, which are well-positioned to participate in the recovery of senior housing that is currently underway.

Starting with Bickford, we are making progress on the disposition of another subset of buildings, which will reduce the size of the lease portfolio to 35 or 36 properties compared to the 48 at the beginning of the year. Following the dispositions, we plan to reset Bickford's annual cash rent to a lease coverage level that makes them a much healthier tenant financially and allows repayment of deferred rent.

From an operations standpoint, we've been encouraged by the rebound in Bickford's occupancy, which increased by 280 basis points from the Q2 to the third and is up 520 basis points from the Q1 . That's more than double the industry growth rate of 210 basis points for comparable assets.

Labor issues should start to subside, driven by accelerating rate growth, and Bickford's margins should recover some of the more than 800 basis points lost due to the pandemic. That is why our agreement includes resetting the lease to a fair market value after two years with a minimum floor. Kevin will provide more details in his comments. Shifting to the Legacy Holiday portfolio, we have disposed of 9 underperforming properties and are evaluating the sale of two others. These properties had been earmarked as possible sales prior to the start of the pandemic.

In fact, the pre-pandemic margins on the 11 properties were more than 1,000 basis points below the remaining 15 we continue to own. That gap widened to over 1,500 basis points during the pandemic.

With the remaining Holiday properties, we are forming two separate joint ventures in RIDEA-like structures with two excellent managers that have extensive experience operating middle-market, independent living communities. We are excited to start a new relationship with Merrill Gardens, a well-established operator based in Seattle that will manage our 6 West Coast properties.

We're also pleased to expand our relationship with Discovery Senior Living through the formation of a joint venture to own and operate 8-9 communities with an East Coast footprint. We are also transitioning the Vero Beach Assisted Living Community to the Discovery Master Lease.

The ventures will be similarly structured with equity contributions from both operators and include value creation and operating cash flow promotes, which we think best align interests as operating performance improves. There is plenty of potential in the legacy portfolio as the pre-pandemic margins were more than 900 basis points higher than current margins, and we're glad to be in a position to capture that upside.

In addition to participating in the operating recovery of these independent living communities, we believe that by entering into these operating joint ventures, we are better positioned strategically to grow our senior housing business with this new product offering. Our progress so far is showing results. We've completed the disposition of 16 underperforming senior housing assets for approximately $173 million. The cap rate on these sales was 3.1% and lease coverage was 0.33x .

We have targeted another 21 underperforming senior housing assets for disposition, which we estimate will generate gross proceeds of approximately $150 million-$155 million with a combined NOI yield in the low single digits and very little lease coverage. We are transforming NHI into a high coverage, high quality portfolio, in other words, a jewel box.

Our balance sheet is in great health as we reduce debt by $150 million during the quarter and currently have full capacity available on our revolver. Considering that cap rates for many of the senior housing asset sales we are contemplating are in the low single digits, we see a nice arbitrage opportunity as we replace them with investments at yields in the mid to high- single- digits.

With nothing drawn on the revolver, additional proceeds coming from dispositions and low leverage, we see little need to issue equity as we resume our external growth. Our current position reminds me of a point in time in our company's history in 2009, when we had no debt on the balance sheet and $100 million in cash. We are eager to turn the page on this chapter of our story and get back to growth with new and existing partners.

While we spend most of our time talking about our assisted living and independent living operators, we wanna point out the exceptional performance of our entrance fee and skilled nursing segments, which represent close to 60% of our annualized cash revenue net of deferrals.

We're fortunate to be in line with these best-in-class operators, and they serve as a blueprint for the long-term stability and growth that we are pivoting back to as a company. I'll now turn the call over to John.

John Spaid
EVP Finance & CFO, National Health Investors

Thank you, Eric, and good afternoon, everyone. Beginning with our net income for diluted common share. For the Q3 ended September 30th, 2021, we achieved $0.67 compared to $0.95 for the same period in 2020. The year-over-year decline in net income is largely due to $6.6 million in lower rent received from Holiday, $5.2 million in additional quarterly rent deferrals provided to other operators, $22.4 million in real estate impairment charges, and the revenue reductions due to dispositions and mortgage repayments since the prior year's Q3.

These declines to net income were partially offset by $19.9 million in gains from the sale of real estate and revenue increases, attributable to $142.2 million of investments and commitment fundings made since the Q3 of 2020.

For our FFO metrics for diluted common share for the quarter ended September 30th, 2021 compared to the prior year, Nareit FFO decreased $0.26- $1.16 from $1.42, and normalized FFO decreased $0.27- $1.15 per share from $1.42. For the quarter ended September 30th, 2021, our normalized FAD declined $9.1 million year-over-year and by $1.7 million sequentially to $51.2 million.

As I previously detailed, the year-over-year and sequential quarterly decline was driven by lower Holiday rent, additional rent deferrals, dispositions, and mortgage repayments offset by investments made over the prior 12 months. Reconciliations for our pro forma performance metrics can be found in our earnings release and 10-Q filed this afternoon at sec.gov.

Our Q3 dividend of $0.90 per share was paid on November 5th, 2021, and represents normalized FFO and FAD total payout total dollar payout ratios of 78.6% and 80.6% respectively. As announced this afternoon, our board declared our Q4 dividend of $0.90 per share for shareholders of record on December 31st and payable on January 31st.

Turning to the balance sheet for the quarter end of September 30st, our net debt to annualized EBITDA leverage ratio improved sequentially to 4.8x from 5.1x . This improvement of leverage was purposeful as the company disposed of low-yielding assets, but it's additionally reflective of the unexpected reduction in Holiday rents.

Our purposeful strategy means that as we enter 2022 and the clouds clear around Holiday, Bickford, and other distressed relationships, we'll be in a position to quickly and accretively redeploy capital. As detailed in our cash flow statement, for the nine-month period ended September 30th, the $163.4 million in net cash flow from investing activities is capital which in large part will allow us to accretively redeploy into new investments without the need for additional equity while still staying comfortably within our stated leverage policy.

Having said that, we're still not done selling low-yielding assets, which we believe we can further redeploy into additional higher yielding investments in a relatively short period of time over the coming quarters.

That's extremely good news for NHI as we enter 2022, and we look forward to next year. On October 31st, we had no amounts outstanding under our $550 million revolver and $74 million in cash. We did not issue any equity through our ATM program during the Q3 and do not expect to issue equity during the Q4 . We continue to have approximately $417 million in capacity available to us under our ATM program.

Our 2017 $800 million revolver and term loan credit facility mature in August of next year. We're in the process of engaging our banking relationships for the re-syndication of our credit facility, and we are targeting closing the facility in the Q1 of 2022.

Regarding the Q4 , we wanna point out a few items that will impact the results. First, we sold two properties in September that contributed approximately $1 million to our Q3 cash revenue. Second, we expect that the Bickford deferrals will be $1 million higher in the Q4 compared to the Q3.

Last, we received approximately $2.3 million in rent payments from Holiday during the Q3. As of today's call, we have yet to receive any payments in the Q4 . We continue to hold an $8.8 million Holiday security deposit, and the final recognition of the deposit will coincide with the termination of the legacy Holiday lease by foreclosure or agreement.

We have made no determination as to how or if any of the deposit will be applied, but we expect a resolution on the deposit in early 2022. With that, I'll now turn the call over to Kevin Pascoe to discuss our portfolio. Kevin?

Kevin Pascoe
CIO, National Health Investors

Thank you, John. The last two years have obviously been challenging, but we have learned quite a bit about what it takes to be successful even in the most difficult business environments. We are using past experience of lessons learned to reposition NHI this year so that we are set up to grow with the very best partners going forward. Our needs-driven senior housing portfolio, which accounts for approximately 31% of our annualized cash revenue net of deferrals, generally experienced solid occupancy gains throughout the quarter.

However, margin growth has not advanced in line with historical trends in occupancy growth, due primarily to increased wages for hourly staff, as well as increased use of agency staffing. On a positive note, residents and their families have been sympathetic to the labor issues, and in multiple instances have been receptive to increased rents to offset the wage growth.

We expect that this trend, coupled with the scheduled 5.9% increase in the Social Security COLA, will lead to much stronger rate growth in 2022. Bickford, our largest assisted living operator, representing 14% of annualized cash revenue net of deferrals, increased quarterly occupancy by 280 basis points sequentially, but labor expenses have been a major hurdle, so we deferred $3.5 million in the Q3.

As Eric discussed, we have reached a preliminary agreement that transforms our Bickford relationship. As we work to complete several more asset sales, we have agreed to defer $4.5 million Q4 rent and up to an additional $4 million Q1 of 2022. We are also working to restructure the leases, which we currently estimate results in annual rents of approximately $28 million.

For reference, we collected approximately $7.8 million in rent from Bickford in the Q3 , and we expect to collect approximately $6.8 million in the fourth. Based on recent operating performance, this reset would improve Bickford's lease coverage after management fee and capital expenditures of $500 per unit to 1.21x from 0.91x . We think this cushion allows for some further near-term margin deterioration as well as potential incremental CapEx.

Following the rent reset, Bickford will use 85% of the leased portfolio's free cash flow to service a deferral balance of approximately $26 million. There are milestones and performance incentives included in the agreement that would reduce this balance, which we view as a strong alignment of interest.

After two years, Bickford's rent will be increased based on fair market value but not be below a floor which is based on an 8% yield on the portfolio's original purchase price. We greatly value our long-standing relationship with Bickford and are hopeful these actions restore stability to this relationship for many years to come. Turning to our independent living communities, this group accounted for only 5% of our annualized cash revenue net of deferrals as we sold 9 Holiday properties for $120 million, which had annualized contractual rent of approximately $9 million.

We have targeted 2 more Holiday properties for sale, which have annualized rent of approximately $1.8 million. In aggregate, we estimate that these 11 properties have lease coverage below 0.5x and margins that are approximately 1,500 basis points below the remaining portfolio.

As Eric noted, we are in the process of transitioning the remaining properties to Merrill Gardens and Discovery, which we expect to happen in early 2022. We are excited to be partnering with these well-established operators and believe this will open up a new path of growth for NHI that supplements our triple net strategy and allows us to participate in the upside as performance recovers from historic lows.

Our entrance fee communities, which account for 27% of our annualized cash revenue net of deferrals, continue to outperform the other senior housing asset classes. EBITDA coverage excluding senior living communities increased sequentially to 1.76x from 1.65x .

Senior living communities, which represent 19% of our cash revenue, had Q3 average occupancy of 80.4%, which was up 190 basis points from the Q2, and was actually higher than the pre-pandemic Q1 of 2022 at 80.3%. The EBITDARM coverage through the Q2 and excluding grant funds was 1.09x , which was down sequentially from 1.13x .

The skilled nursing portfolio, which represents 32% of annualized cash revenue net of deferrals, is anchored by NHC and the Ensign Group, who contributed 15% and 9% of annualized cash revenue, respectively. SNF EBITDARM coverage for the trailing twelve months ended June 30th was 2.8x , including 3.82x at NHC and 2.1x at our other medical properties.

Turning to our business development activities. Year to date, we have announced over $120 million of investments at a weighted average yield of nearly 9%. We did not make any new investments during the Q3 , but activity with our partners at Montecito has picked up recently, so we expect to fund multiple projects before the year-end and still estimate that the fund will be fully invested within 2 years from inception.

The pipeline remains active across multiple asset classes and product types, but it has been a better seller's market, which has certainly worked to our advantage this year. As we conclude our disposition program, we expect to be more active rebuilding the pipeline in 2022. With that, I'll hand the call back over to Eric.

Eric Mendelsohn
President and CEO, National Health Investors

Thank you, Kevin. We are repositioning NHI to emerge as a stronger company going into 2022. We are making steady headway and expect that our portfolio optimization activities will be complete by the end of the Q1 of 2022. We believe that repositioning is in the best long-term interests of our stakeholders and are very optimistic about the future for several reasons.

First, we fully expect that senior housing fundamentals will recover, driven in near term by easing compensation pressure and unprecedented rent growth. Over the longer term, as the supply and demand dynamics start to tilt in our favor, we see years of consistent growth ahead for the industry. Second, we are set up for strong long-term organic growth.

We expect deferral balances to start repaying in 2022, and our new joint ventures position NHI to participate directly in the upside of the senior housing recovery. Third, our low-levered balance sheet will only improve as cash flow stabilizes, and with plenty of access to capital, we are able to drive strong acquisitive growth, which is made more accretive as we have limited need to issue equity. Operator, we'll now turn the line over for questions.

Operator

Thank you. Please to ask a question please press one followed by four on your telephone, you will receive a prompt on your request , if your question is not been answered and you would like to retry please press one followed by three. We do have a question from the line of Jordan Sadler with KeyBanc Capital Markets. Please go ahead. Your line is open.

Jordan Sadler
Managing Director, KeyBanc Capital Markets

Thanks, guys. Wanted to dig in a little bit. There's a little bit more going on this quarter than I anticipated, particularly as it related to Bickford and the rent cuts. I was kind of curious if you could maybe walk us through how you arrived at what looks to be about an 18% rent cut for Bickford, and correct me if I'm wrong there at this point in time, and when that sort of goes into effect exactly. Thank you.

Kevin Pascoe
CIO, National Health Investors

Sure. Hey, Jordan, it's Kevin. I would tell you that we looked at the portfolio as currently constructed, but then also looking at the dispositions that we're evaluating here over the next 3-6 months and the underlying NOI for those buildings and what they could support both now and then with those buildings removed.

Then from there, looking at, again, what they could support now and projecting forward on some occupancy improvement over time, where we think they would have a reasonable amount of cash flow above and beyond that to continue to service the deferred rent amounts. We're looking at, as a starting point, in-place cash flow for the buildings and what we think they can support, subtracting out the buildings that we're looking to move away from, and then ultimately, what does that new portfolio look like?

Them still being able to service that rent payment along the way to the extent maybe some of those buildings take a little longer to sell or there's some new ones that come in or go out, so to speak. We think we have a good strategy in terms of which ones are moving. Again, those can move maybe one or two different buildings here and there.

By and large, the underlying portfolio can support the rent number based on current performance. That, again, was kind of the starting point, and then looking for them to continue to grow, occupancy margins to settle out a little bit where we have seen some wage pressure here and there, across the portfolio, not only with Bickford.

You know, if that continues or if that starts to settle out, then they should be able to start to service that deferred rent.

Jordan Sadler
Managing Director, KeyBanc Capital Markets

Okay. How did you arrive at the degree of the rent cut? Was it just based on pro forma lease service coverage ratio? I'm trying to understand the delta between the $46 million on page four of the deck here, $46 million- $37.7 million.

Kevin Pascoe
CIO, National Health Investors

Right. Yeah. The $37.7 million that you mentioned is the portfolio minus the 7 buildings that we're looking at disposition currently. Then furthermore, the rent cut to $28 million is what we believe the portfolio can service today based on current NOI. We're expecting that step down from the $46 million, really the $37.7 million, to the $28 million beginning next year. Then after 24 months, that rent will then be reset to what we believe should be a more stabilized portfolio at that time.

Jordan Sadler
Managing Director, KeyBanc Capital Markets

It's a minimum of an 8, right? On the basis in those assets?

Kevin Pascoe
CIO, National Health Investors

Correct. Yeah, on the original basis, not the depreciated basis.

Jordan Sadler
Managing Director, KeyBanc Capital Markets

Do you know what that is offhand?

Kevin Pascoe
CIO, National Health Investors

Well, I can give you some goalposts. Based on-

Jordan Sadler
Managing Director, KeyBanc Capital Markets

Yeah

Kevin Pascoe
CIO, National Health Investors

... the disposition of the seven, that number would be between $32 million and $33 million. Again, if there's some additional sales along the way or if a building turns and we elect not to sell it, that number will change a little bit. Ultimately, according to the plan that we have right now, it would be in that $32 million-$33 million.

Jordan Sadler
Managing Director, KeyBanc Capital Markets

That's the 8% floor.

Kevin Pascoe
CIO, National Health Investors

Correct.

Jordan Sadler
Managing Director, KeyBanc Capital Markets

Okay. Just on the JV agreements, what is the base management fee or in place, you know, and/or the in-place NOI from these assets? I tried to sort of back into it, based on sort of the lease coverage, the LSCR, and what the prior rent was, and I got to, like, a $15 million number for NOI. I could use maybe a little bit of help trying to understand how we get, you know, we were at $21 million for these 14, 15 assets that are going into the JV. Where does that go kind of, January?

Kevin Pascoe
CIO, National Health Investors

You're asking what's the management fee for the-

Jordan Sadler
Managing Director, KeyBanc Capital Markets

Plus the NOI, yeah. The way to structure the JV. I mean, what the percentages are. I'm just trying to understand what these numbers are gonna look like compared to the previous in-place rent.

Kevin Pascoe
CIO, National Health Investors

Yeah. Well, I guess I would say to that end, we're, with most companies or in most management agreements we're seeing, there's a 5% management fee, but there's also incentives that get put in there along the way for certain performance hurdles, and we wanna make sure that the managers are properly incentivized. You know, the base fee would be that, around that 5%.

Jordan Sadler
Managing Director, KeyBanc Capital Markets

Am I about right on the in-place NOI, that $15 million?

Kevin Pascoe
CIO, National Health Investors

You're looking at for the remaining 15 buildings?

Jordan Sadler
Managing Director, KeyBanc Capital Markets

Yeah, yeah. Page six, you've got the pro forma LSCR of 0.73x, and I'm basically assuming that you're using the 0.73 lease service coverage ratio off of a rent of combined $21 million, $21.4 million on the two portfolios combined.

Kevin Pascoe
CIO, National Health Investors

Yeah. We'd be looking at an NOI a little bit higher than that. I mean, you're

John Spaid
EVP Finance & CFO, National Health Investors

Hey, Jordan, we don't mean to be cagey, but, you know, we're gonna go through a little bit of a transition with the properties. We'll give you. This is John. We want to give the Street a good set of guidance in February. But keep in mind, there's gonna be some transition.

Then, in addition to that, you know, we gave you some idea that in the past, you know, the numbers we had given you represented roughly the NOI from these properties, you know, based upon the net deferrals before the properties were transferred to Welltower and Atria. But, you know, there's $6 million-$8 million of NOI upside in these properties if we can get to pre-pandemic levels.

There'll be a little bit of movement on that as we get there.

Jordan Sadler
Managing Director, KeyBanc Capital Markets

When would the transition date be effective essentially for these two portfolios?

Kevin Pascoe
CIO, National Health Investors

This is Kevin again. We're gonna target the first of the year.

Jordan Sadler
Managing Director, KeyBanc Capital Markets

Okay

Kevin Pascoe
CIO, National Health Investors

with any transition. You know, there's movement, but at the end of the day, that's what our goal is.

Jordan Sadler
Managing Director, KeyBanc Capital Markets

Okay. Thank you, guys.

Kevin Pascoe
CIO, National Health Investors

Thank you.

John Spaid
EVP Finance & CFO, National Health Investors

Thanks, Jordan.

Operator

Our next question is from Juan Sanabria with BMO. Please go ahead, your line is open.

Juan Sanabria
Managing Director, BMO Capital Markets

Hi, good morning, or sorry, good afternoon. It's been a long day. On Jordan's question on Holiday, could you just talk a little bit about the structure in terms of the upside, should we think of it as similar to the way you guys did Bickford was more of a triple net than a true shop structure? And what's the ownership split between you and Merrill Gardens and Discovery out on that venture?

Kevin Pascoe
CIO, National Health Investors

Sure. This is Kevin. This one's gonna be different than Bickford in that, while NHI will still be the large majority owner, there's not going to be a lease in place like there was with Bickford. There we had a separate OpCo, PropCo split. Here we're anticipating what we'd refer to as a back-to-back management agreement. We're partners with them on the real estate and really the whole venture together.

The ownership between Discovery and Merrill is a little bit different. We're not yet at a place where we're ready to talk about specific numbers, but it suffices to say it'll be a meaningful amount to each one of those organizations that they're putting in, and we're gonna have appropriate incentives and, you know, carrots for these properties to perform.

We would couch it, I should say, as a meaningful amount to each one of them and feel like it provides good alignment for the venture we're doing. A point of clarity is that they are both cutting a check to come into the venture with us.

Juan Sanabria
Managing Director, BMO Capital Markets

Okay. Hey, can you

John Spaid
EVP Finance & CFO, National Health Investors

Juan, I don't know if.

Juan Sanabria
Managing Director, BMO Capital Markets

Sorry, John.

John Spaid
EVP Finance & CFO, National Health Investors

I was gonna just add, you know, these will be shop portfolios. They will, you know, we'll structure them with some synthetic debt, and then they'll each own, you know, some portion of the equity. We think we know what those numbers are. We're not yet ready to share that with you. You know, but, you know, the vast majority, over 90% of the capital will still be provided by us.

Juan Sanabria
Managing Director, BMO Capital Markets

Okay. Hey, can you comment on your confidence or lack thereof, and ability to get to the unpaid rents by Holiday and the credit behind that lease with Welltower?

Eric Mendelsohn
President and CEO, National Health Investors

Hey, Juan, this is Eric. That is obviously a sensitive legal topic, so I hesitate to speculate on an earnings call. Just know that we are focused on recovering that and that the balance sheet information we receive from Atria indicates that those funds are accruing on the buildings' balance sheets.

Juan Sanabria
Managing Director, BMO Capital Markets

Going back to Bickford, is it right to think that you. It sounds to me that you have decided to cut rents on, based on current performance and cash flows despite visibility on the upside for these next two years with maybe the offset that you get repaid that, the amount that's been deferred, rather than the giving them a lower coverage day one and kinda maybe sacrificing that repayment of deferrals, but not giving kind of a two-year rent cut. Is that the right way to think about it?

Eric Mendelsohn
President and CEO, National Health Investors

That's a way to think about it. The reason we did that is because the repayment of the deferrals will most likely be lumpy and dependent on the recovery of the buildings, the margins from the labor expenses. We wanted a rent number that we could depend on that was backed up by coverage. We think it's important to show investors that our leases have good coverage and that the rents are solid. Finally, as John said, we're endeavoring to give you guidance in our February earnings call. All of that went into the thinking on how we structured this.

Juan Sanabria
Managing Director, BMO Capital Markets

Just last question for me. Can you give us any sense of, I know that there's still a lot of moving pieces about what the pro forma dividend coverage will be kinda come, I guess, at the end of the Q1 2022 when this is all kinda washed out, and the comfort level there?

John Spaid
EVP Finance & CFO, National Health Investors

I'd say this is John, Juan. I'd say we have very high degree of confidence in our payout ratio being, you know, where we think it'll be, which is, you know, say low 80s to even below 80%. A lot of that's gonna have to do with how, you know, getting these joint ventures closed and temporarily maybe some transition costs that show up in the Q1 .

We just can't give you guidance on that just yet. The Q4 though, you'll note that we've talked a little bit about a little heavier deferrals in the Q4. You should, you know, expect some increase in the payout ratio as a result of that. Don't be surprised by that.

We have a high degree of confidence that it's gonna be very, very short-lived.

Juan Sanabria
Managing Director, BMO Capital Markets

Thank you.

Operator

Our next question is from Rich Anderson with SMBC. Please go ahead. Your line is open.

Rich Anderson
Managing Director, SMBC Nikko Securities America

Thanks. Good afternoon. So, you know, when listening to other calls, this earnings season, particularly from your large-cap peers, you know, there's a lot more enthusiasm about the future and the senior housing space. I'm curious if you would be having similar undertones to your tone and if we're really specifically talking about very company specific issues that, you know, that you perhaps missed in the underwriting or whatever.

Why, you know, what do you think happened to have such a tough path, and it's been tough for everybody, but, you know, there's a lot more enthusiasm away from you today from other REITs. What do you think it is? You know-

Eric Mendelsohn
President and CEO, National Health Investors

Uh, good-

Rich Anderson
Managing Director, SMBC Nikko Securities America

Your specific position. Go ahead.

Eric Mendelsohn
President and CEO, National Health Investors

Good marketing and good voice coaches.

Rich Anderson
Managing Director, SMBC Nikko Securities America

Is that really your-

Eric Mendelsohn
President and CEO, National Health Investors

You know.

Rich Anderson
Managing Director, SMBC Nikko Securities America

Your final answer?

Eric Mendelsohn
President and CEO, National Health Investors

Rich, you know, it's not lost on us that there's a lot of cheerleaders in this business. I think if you read the transcripts from our prepared remarks, you'll see optimism there. You'll see the way that we structured the restructuring of Bickford and of Holiday, that it allows us to participate in the upside. All of that, we believe, will bode well for 2022 and beyond.

There's optimism there, you know, and I would also point with a yellow highlighter to the part in our prepared remarks where Bickford is knocking it out of the park. They are leading in terms of occupancy, way ahead of NIC, way ahead of other REIT SHOP portfolios. You know, they're in the 80s. A lot of portfolios are still in the 70s.

So, You know, don't let my monotone voice convince you that I'm not enthusiastic. I am. You know, we're trying to signal to the market and to the analyst communities that we have increased confidence in 2022. We declared a dividend this quarter. We didn't wait as we have been. We've signaled we wanna give guidance for 2022 in February, where we didn't give guidance this year. Our payout ratio is adjusted and, you know, we think we got that right. We think that the amount that we cut is gives us the breathing room to do these dispositions and rights the ship, if you will, for future dividend growth.

There's a lot of good optimistic signals in our prepared remarks and in the progress report that we also distributed this morning as part of our release.

Rich Anderson
Managing Director, SMBC Nikko Securities America

Yeah.

Eric Mendelsohn
President and CEO, National Health Investors

You know, we feel like we've made good progress on restructuring all of the things that needed to be restructured.

Rich Anderson
Managing Director, SMBC Nikko Securities America

Okay. Well, yeah, we appreciate the candor for sure. So, don't take the question the wrong way. Now, the other thing is, you know, rate growth, and you said it yourself, unprecedented rate growth. Does a lot of that or most of that hit in the very early part, maybe January 1st of next year? I'm just curious if you can outline the timing of when, you know, offers start going out and when we could start seeing some of that.

Kevin Pascoe
CIO, National Health Investors

Sure. Hey, Rich, it's Kevin. I would say that it'll be over the course of the year. Yes, most operators target the beginning of the year. Some do it on the anniversary date of the resident, but that's probably the exception more so than the rule. Most of what we're seeing will be more Q1 . We've heard a range anywhere from 5%-10% even. I would say most of our operating partners are gonna be asking more in that 5%-6% range, which again, that's gonna step up rents to try and cover the labor that's going out.

We've also heard that there's going to be some groups that are looking at more of a, almost like a labor surcharge to help cut down on the amount of overhead that's continuing to build here. We think there's a good possibility that there will be good rate growth for the year. There's an effort to mitigate the expenses.

We do think also that if they can get people to come back to the workforce and they can mitigate some of the agency and overtime, that'll help. The fact of the matter is wages are up, so that's gonna be a little bit of a headwind still. The rates should help, you know, keep that abated to some degree.

Rich Anderson
Managing Director, SMBC Nikko Securities America

Is it true that residents are, like, saying, "Yeah, I'll pay you more to cover your labor costs?" I mean, it seems like such a nice thing to do, but is that really happening or is that almost, you know, that's the market and so they're just having to pay it or going to have to pay it?

Kevin Pascoe
CIO, National Health Investors

Well, I'd say it's probably a blend of the two. It's people aren't signing up to get charged more. At the same time, when you have these resident council meetings and they understand and they talk to family members, they understand what's going on. They see it elsewhere. They understand that prices are going up, so they're not cheerleading you, but they understand it. And it is the market. So to the extent that,

You know, there are some people that are doing 8%, 9%, 10% to the extent you're doing 5, 6, 7, which would still be considered exceptional. You know, that's perhaps a little more palatable.

Rich Anderson
Managing Director, SMBC Nikko Securities America

Kevin, my last question is, when you came up with the Bickford restructuring, you know, after first the sales and then the, you know, right size the coverage and everything, all the steps that you went through, what did you assume in rate growth in, you know, in underwriting that decision?

Kevin Pascoe
CIO, National Health Investors

Yeah. They're gonna be in line with what we just told you, that

Rich Anderson
Managing Director, SMBC Nikko Securities America

Okay.

Kevin Pascoe
CIO, National Health Investors

5%-6% is what we're expecting. As we've talked about, you know, the wage pressure is still very real. We also said that we allowed for some near-term margin compression as we, you know, go through the winter months and get into the Q1.

You know, they're gonna be in line with what we're seeing from our other operating partners, but we're also trying to give them some, you know, wiggle room, so to speak, to start paying back these preferred balances. That's gonna be the upside that we capture to the extent we did cut a little low. It just means we get paid back a little faster.

Rich Anderson
Managing Director, SMBC Nikko Securities America

I'm sorry, one more. I know the deferred balance for Bickford is $26 million, I think is right. What's the total deferred balance?

Kevin Pascoe
CIO, National Health Investors

Well, the 26 is gonna be the anticipated total. That includes the Q1 .

John Spaid
EVP Finance & CFO, National Health Investors

Rich, we're well over $40 million, including some other notes that we've not taken into cash income, such as the second mortgage on the 6 properties that we sold to Bickford earlier this year. As Kevin mentioned, that includes what we expect to defer in the fourth and the Q1 of next year. You know, what we're doing is we're using some of those deferrals as a performance incentive as well.

They hit certain hurdles, and we'll forgive a portion of those deferrals. But you know, when you look at those coverage ratios that we also displayed in our forecast to you in our presentation to you today also, we're. Keep in mind, we're using $500 per unit CapEx.

We think their actuals will be a little heavier. We don't wanna have to come back and talk to you again about another rent cut. So that was part and parcel of our discussion and where we settled on. You know, when they do have excess cash flow, we do expect to be able to collect it and collect it through these deferrals.

Rich Anderson
Managing Director, SMBC Nikko Securities America

Okay. When you start reporting FFO in 2023, I mean, you could have big, big growth numbers. You know, you have to be careful how you communicate that, I guess, right? That's a problem.

John Spaid
EVP Finance & CFO, National Health Investors

Yeah. We'll have to be very careful about that. We'll have to help you know, with bridging through that. You know, we'll have other things that will make its way down to the FAD line, including $8.8 million in deposits that we hold on Holiday. We fully expect to be able to collect rent on Holiday. I don't want you to think that we're sitting here saying that that's not gonna happen.

We're gonna have some discussions about that coming up. You know, once we get through this period of time, and we get into those discussions, there's another spot where you'll see some lumpiness. Yes, we'll have to help you bridge all that.

Rich Anderson
Managing Director, SMBC Nikko Securities America

Yeah. Great.

John Spaid
EVP Finance & CFO, National Health Investors

to get to a stabilized number.

Rich Anderson
Managing Director, SMBC Nikko Securities America

Well, at least it's interesting. Thanks, guys.

Kevin Pascoe
CIO, National Health Investors

Thanks, Rich.

Operator

Our next question is from Daniel Bernstein with Capital One. Please go ahead. Your line's open.

Daniel Bernstein
Director, Senior REIT Analyst, Capital One Securities

Hi. Good evening. Just wanted to go back to the Holiday JVs and just kinda understand you know how much deferred CapEx might be there. I'm sure you're still figuring this out, but kind of how we should think about your CapEx obligations as part of those JVs.

Kevin Pascoe
CIO, National Health Investors

Sure. Hey, Daniel, it's Kevin. I would tell you that in, generally speaking, the buildings have been maintained. That said, as we've seen in the portfolio, and not unique to this group, that, you know, CapEx has been a little, or I'd say maintenance has been a little deferred. Just, you know, maybe some carpets need to be replaced or walls painted and so forth, you know, so on and so forth. We are, as a part of our capitalization, though, for each one of these joint ventures, allowing for, you know, pretty sizable amount of CapEx to be put into each of the two portfolios.

We'll capture that on the front end, make sure that these are up to speed in terms of making good first impressions and for the new operating partners to be able to sell into the market.

Daniel Bernstein
Director, Senior REIT Analyst, Capital One Securities

I wanted to kind of understand on Holiday how much rent was actually booked in 3Q. I thought it was $600,000, but I just wanted to make sure I understood what was being booked in FFO and FAD, given that you didn't use any of that $8.8 million or didn't draw down much of that $8.8 million dollar deposit.

John Spaid
EVP Finance & CFO, National Health Investors

You know, Daniel, we originally had $10.6 million in deposit. 600,000 of that was used in the Q3. FAD that was recognized was $2.3 million in the Q3.

Daniel Bernstein
Director, Senior REIT Analyst, Capital One Securities

Okay.

John Spaid
EVP Finance & CFO, National Health Investors

I understand it includes a little piece of that deposit that I just mentioned to you.

Daniel Bernstein
Director, Senior REIT Analyst, Capital One Securities

Right. Just going back to the JVs and the pipeline and kind of expectations for investments in 2022, I mean, you've done some kind of SHOP-like JVs before on a small scale, but this seems like, you know, you're much more positive about the recovery in the space and maybe would use these JVs as a, I guess, a platform to increase the amount of RIDEA-like assets in your portfolio.

Outside the assets that you're donating to these JVs, are there other assets that you've identified within your portfolio you might donate to those JVs? Are you thinking about in 2022 expanding the JVs through acquisitions?

Eric Mendelsohn
President and CEO, National Health Investors

Good question, Daniel. This is Eric. You're right. We're excited about this, and it does have potential as a new platform. Most of our other properties are still in triple net leases, so it might not be possible to put them into the JV. The current operators have something to say about that. It certainly could be a platform for growth and for new acquisitions. We're hopeful that'll be the case.

Daniel Bernstein
Director, Senior REIT Analyst, Capital One Securities

Okay. All right. I'll hop off. Thanks for taking the questions.

Eric Mendelsohn
President and CEO, National Health Investors

Thanks, Daniel.

Operator

We have a question from Omotayo Okusanya with Credit Suisse. Please go ahead, your line's open.

Omotayo Okusanya
Managing Director, Equity Research, Credit Suisse

Hi. Yes, good evening, everyone. I just wanted to follow up on Rich's question about Bickford. Kev, I think you gave some general guidelines around, you know, assumptions that were made about the portfolio recovery as it pertains to, you know, OpEx, labor, possibly, also kind of rental growth. Could you talk a little bit more about just other assumptions you may be making, that led you to feel confident that the way this is being structured, that they will be able to pay the newly established rent rates and as well as all the deferrals?

Kevin Pascoe
CIO, National Health Investors

Sure. Yeah, this is Kevin. We mentioned in our prepared remarks what our collections from Bickford were for the Q3 and what we expect for the Q4 , which again triangulate that $28 million run rate that we went through. Over the last few months, we've seen them be at the highest level that they've been in history in terms of the amount of agency and overtime usage and their labor costs.

Even if they hold steady, we feel reasonably good about their ability to continue to service the rent going forward in the next year. Based on current occupancy, current rates without additional rate growth, we believe they should be able to service the rent, the $28 million rent number.

Getting rid of the buildings, their ability to execute on limiting agency and overtime and getting labor under control, you know, the number of things that we've mentioned will contribute to them being able to increase their NOI over time. To date, we've seen them increase occupancy between 50 and 100 basis points a month. We use that as also a signal in terms of how we are looking at the next 12 to 24 months and how we are looking at their opportunity to increase their NOI.

They have a lot of factors going on, but again, I think the key here is that based on the current trailing information that we have, and even where we're seeing labor and rates today, we believe they should be able to service that rent payment. Then assuming they can get the labor piece under control and have occupancy and rate growth, then that's what's gonna be able to help the deferral component.

Omotayo Okusanya
Managing Director, Equity Research, Credit Suisse

Gotcha. Okay, that's helpful. And then again, pardon me because I'm a little rusty. I've been out of the game for a couple of months. The smaller tenants you used to have in your portfolio that were kind of in transition, they were in lease up, there were a small handful of them, you know, smaller RIDEA type transactions.

I think some of them may even have been triple net transactions. Could you just kind of talk about what's happening with those names? Because again, pre-pandemic, you know, occupancies were still in lease up mode. They've obviously gone down since then. Like, that small pool of tenants, is there anything there that we should be thinking about, that may be a potential drag to earnings going forward, just kind of given the prolonged pandemic?

Eric Mendelsohn
President and CEO, National Health Investors

That's a great question, Omotayo . This is Eric, and welcome back to the game.

Omotayo Okusanya
Managing Director, Equity Research, Credit Suisse

Thank you.

Eric Mendelsohn
President and CEO, National Health Investors

We took a hard look at some of those properties, and the way we thought about it is, here's a nugget of value that isn't generating any NOI. Is it gonna generate NOI in the near future? Because if it's not, we happen to have this unique situation where the disposition market is very robust, and you can turn that underperforming building into cash and either pay down debt or reinvest it in something that is going to give you immediate NOI and returns. Several of those buildings ended up on our disposition list, and you can see what that looks like on page 7 of the slide deck that we added to our webpage.

you know, granted, after we did that underwriting and re-underwriting, there were a couple of buildings that we believe in markets that we believe in, that we're gonna be patient and hold on to them to experience the recovery. But there's some that, you know, they weren't doing well before the pandemic, they're not doing well during the pandemic, but they can fetch a very good price. That's our approach to those buildings.

Omotayo Okusanya
Managing Director, Equity Research, Credit Suisse

Great. Thank you.

John Spaid
EVP Finance & CFO, National Health Investors

Hey, Omotayo , this is John. On slide 7, you'll see there are 21 assets-

Omotayo Okusanya
Managing Director, Equity Research, Credit Suisse

Yeah.

John Spaid
EVP Finance & CFO, National Health Investors

Yeah, in that. See that line there in the in progress line?

Omotayo Okusanya
Managing Director, Equity Research, Credit Suisse

Yep.

John Spaid
EVP Finance & CFO, National Health Investors

Those 21 assets include, you know, say 2 Holiday assets, not yet disposed, 7 Bickford assets that we talked about on other slides, and then approximately 12 of these other assets that we've been talking about that gets to your question regarding smaller tenants.

Omotayo Okusanya
Managing Director, Equity Research, Credit Suisse

Great. Thank you.

John Spaid
EVP Finance & CFO, National Health Investors

You're welcome.

Operator

There are no further questions at this time.

Eric Mendelsohn
President and CEO, National Health Investors

Thank you, everyone, for your time and attention today, and we'll see some of you tomorrow at NAREIT.

Operator

That concludes the call for today. We thank you for your participation. As always, please disconnect your line.

Powered by